Showing 1611-1620 of 9134 results for "".
Pushing the Envelope in PN Research
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37181/Raja Sivamani, MD, MS, AP, an integrative dermatologist and Adjunct Associate Professor of Clinical Dermatology at the University of California, Davis, discusses how research to help understand different aspects of prurigo nodularis can help develop therapeutics that can be life-changing for patientCoding for Superficial Radiation Therapy
https://practicaldermatology.com/series/c-suite-chats/coding-for-superficial-radiation-therapy/56364/Joseph C. Sardano, Chairman and CEO of Sensus Healthcare, discusses the issue of insurance denials for noninvasive skin cancer treatments such as superficial radiation therapy (SRT), and a new solution for ensuring predictable payment.SAFE Step Act Update
https://practicaldermatology.com/series/skin-minute/safe-step-act-update/54846/Colby Evans, MD, former chair of the National Psoriasis Foundation Board of Directors, discusses the progress of the SAFE Step Act, which he said continues to garner bipartisan support and could advance in Congress this year.The War Zone: Private Practice
https://practicaldermatology.com/series/the-practical-dermatology-podcast/the-war-zone-private-practice/54847/The War Zone: Private PracticePractical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Editorial Board member Collin Blattner, DO, FAAD, discuss strategies for building a successful private practice in the era of private equity, as well as the challenges associated with it.Strategies for Treating Patients on GLP-1 Receptor Agonists and More
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/strategies-for-treating-patients-on-glp-1-receptor-agonists-and-more/54646/Suneel Chilukuri, MD, discusses key takeaways from the “What’s My Treatment? How to Combine Dermal Filler, Neuromodulators, Laser/Light/RF Devices/Microneedling and Cosmeceuticals Symposium” workshop at Maui Derm Hawaii 2026.Food Allergies and Atopic Dermatitis in the Pediatric Population
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/food-allergies-and-atopic-dermatitis-in-the-pediatric-population/37175/Elizabeth Lippner, MD, MA, Attending Physician in the Division of Allergy and Immunology and Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine, discusses potential links between food allergies and pediatric atopic dermatitis, and how to address them.Innovation in Androgenetic Alopecia
https://practicaldermatology.com/series/c-suite-chats/innovation-in-androgenetic-alopecia/54265/Diana Harbort, President of Cosmo Pharmaceuticals' Dermatology Division, discusses the need for new innovations in androgenetic alopecia and the promise of clascoterone for treating the condition.DWTV Extra: Skin and Scalp Health
https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-skin-and-scalp-health/54147/Chesahna Kindred, MD, MBA, FAAD, discusses an event at the Science of Skin & Scalp Studio in New York, New York, featuring interactive rooms led by dermatologists, beauty experts, and influencers living with chronic inflammatory conditions sharing stories and shaping the conversation around skinDermwire TV: 2025 in Review
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-2025-in-review/54093/Dermwire TV takes a look back at the most popular stories from the Practical Dermatology news and multimedia ecosystem.Dermwire TV: Ruxolitinib Cream 1.5% Effective for AD Improvement, Stapokibart Shows Promise
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-ruxolitinib-cream-15-effective-for-ad-improvement-stapokibart-shows-promise/49101/This episode highlights new research showing ruxolitinib cream 1.5% providing itch relief and broader atopic dermatitis (AD) improvement, as well as a post-hoc analysis finding safety and efficacy for stapokibart in elderly adults with AD; and Excellergy executives discuss how recent research valida